US 9474796
Crimean-Congo hemorrhagic fever virus vaccine
granted A61KA61K2039/5254A61K39/12
Quick answer
US patent 9474796 (Crimean-Congo hemorrhagic fever virus vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/5254, A61K39/12